| 书目名称 | Practical Management of Thyroid Cancer | | 副标题 | A Multidisciplinary | | 编辑 | Ujjal K. Mallick,Clive Harmer | | 视频video | | | 概述 | Covid-19 pandemic and thyroid cancer -- lessons learnt.Artificial intelligence in thyroid cancer.Genomics based platform trials, tumour agnostic drugs | | 图书封面 |  | | 描述 | .Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer..It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic..The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed..The l | | 出版日期 | Book 2023Latest edition | | 关键词 | Thyroid Cancer; COVID-19 Pandemic and Thyroid Cancer; Recent Breakthroughs in Management; New Genomics | | 版次 | 3 | | doi | https://doi.org/10.1007/978-3-031-38605-3 | | isbn_softcover | 978-3-031-38607-7 | | isbn_ebook | 978-3-031-38605-3 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 19:36:15
